Procter & Gamble
PG
$142.39
+0.58%
Procter & Gamble is a global leader in the consumer defensive sector, manufacturing and selling a vast portfolio of household and personal care products, including iconic brands like Tide, Pampers, and Gillette. The company is a dominant market leader with unparalleled scale, brand equity, and distribution, operating as a defensive stalwart in the consumer staples industry. The current investor narrative centers on its ability to navigate persistent input cost inflation and foreign exchange headwinds while maintaining pricing power and market share, with recent attention also focused on its status as a premier dividend growth stock boasting 69 consecutive years of payout increases.…
PG
Procter & Gamble
$142.39
Related headlines
PG 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Procter & Gamble's 12-month outlook, with a consensus price target around $185.11 and implied upside of +30.0% versus the current price.
Average Target
$185.11
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$114 - $185
Analyst target range
Analyst coverage for this large-cap staple is limited in the provided data, with only 7 analysts noted, which is lower than typical for a company of its size, suggesting coverage may be consolidated among major firms. The consensus sentiment appears mixed but leans cautiously optimistic, as evidenced by recent institutional actions including an upgrade from JP Morgan to 'Overweight' and a maintained 'Buy' from UBS in January 2026, though TD Cowen downgraded to 'Hold' in the same period. Without explicit average target price data provided, the implied upside cannot be calculated, but the range of recent analyst actions and the stock's defensive characteristics suggest targets likely cluster around current levels with a modest premium, reflecting a balance between its quality and growth challenges.
PG Technical Analysis
The stock is in a pronounced downtrend, having declined 12.83% over the past year and currently trading at $141.57, which is just 23.6% above its 52-week low of $137.62. This positioning near the lower end of its annual range suggests the stock is in a value zone but could also indicate a 'falling knife' scenario if the fundamental outlook deteriorates further. Recent momentum remains negative, with the stock down 11.56% over the last three months and 1.26% over the past month, indicating the selling pressure has persisted into the short term and is consistent with the longer-term downtrend. The stock's beta of 0.398 highlights its defensive, low-volatility nature, as it has significantly underperformed the market, evidenced by a -38.02% 1-year relative strength versus the SPY. Key technical support is clearly defined at the 52-week low of $137.62, while resistance sits at the 52-week high of $170.99; a decisive break below support could trigger a new leg down, whereas a recovery would need to overcome significant overhead supply.
Beta
0.40
0.40x market volatility
Max Drawdown
-19.1%
Largest decline past year
52-Week Range
$138-$171
Price range past year
Annual Return
-12.8%
Cumulative gain past year
| Period | PG Return | S&P 500 |
|---|---|---|
| 1m | -3.1% | +4.0% |
| 3m | -10.8% | +8.2% |
| 6m | -3.1% | +11.5% |
| 1y | -12.8% | +24.3% |
| ytd | +0.4% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PG Fundamental Analysis
Revenue growth is modest but positive, with the most recent quarterly revenue of $22.21 billion representing a 1.49% year-over-year increase; however, this marks a deceleration from the prior quarter's $22.39 billion, indicating potential top-line pressure. The company remains highly profitable, reporting net income of $4.33 billion for the quarter with a robust gross margin of 51.22%, though the operating margin of 24.16% shows some compression from the 26.17% reported in the previous quarter. Profitability metrics are strong, with a return on equity of 30.71% and a net margin of 18.95%, reflecting the company's premium brand positioning and pricing power. The balance sheet is healthy with a manageable debt-to-equity ratio of 0.68, and the company generates substantial cash, evidenced by trailing twelve-month free cash flow of $14.85 billion, which comfortably funds its dividend and share repurchases, as seen in the latest quarter's $2.54 billion dividend payout and $2.28 billion in stock buybacks.
Quarterly Revenue
$22.2B
2025-12
Revenue YoY Growth
+0.01%
YoY Comparison
Gross Margin
+0.51%
Latest Quarter
Free Cash Flow
$14.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PG Overvalued?
Given its consistent profitability, the primary valuation metric is the P/E ratio. The stock trades at a trailing P/E of 24.48x and a forward P/E of 19.97x; the forward multiple's discount to the trailing figure implies the market expects earnings growth, likely from margin recovery or cost savings. Compared to sector averages, P&G's valuation commands a significant premium; for instance, its Price-to-Sales ratio of 4.64x and EV/EBITDA of 17.43x are elevated relative to many consumer staples peers, a premium justified by its superior brand portfolio, global scale, and consistent profitability. Historically, the current trailing P/E of 24.48x sits below its own recent peak observed in the Q1 2026 period (19.71x on a quarterly basis, though historical data shows higher annualized figures), suggesting the multiple has contracted from more optimistic levels, potentially offering a more reasonable entry point if fundamentals stabilize.
PE
24.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 19x~32x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.4x
Enterprise Value Multiple
